Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Long-Term Investments (2020 - 2025)

INVO Fertility has reported Long-Term Investments over the past 6 years, most recently at $2.5 million for Q3 2025.

  • Quarterly Long-Term Investments rose 219.61% to $2.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Sep 2025, up 219.61% year-over-year, with the annual reading at $740759.0 for FY2024, 19.15% down from the prior year.
  • Long-Term Investments was $2.5 million for Q3 2025 at INVO Fertility, up from $645944.0 in the prior quarter.
  • Over five years, Long-Term Investments peaked at $2.5 million in Q3 2025 and troughed at $141267.0 in Q2 2021.
  • The 5-year median for Long-Term Investments is $997725.0 (2023), against an average of $1.0 million.
  • Year-over-year, Long-Term Investments soared 1419.04% in 2021 and then fell 28.48% in 2024.
  • A 5-year view of Long-Term Investments shows it stood at $1.5 million in 2021, then fell by 16.92% to $1.2 million in 2022, then decreased by 25.98% to $916248.0 in 2023, then decreased by 19.15% to $740759.0 in 2024, then skyrocketed by 233.01% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Long-Term Investments are $2.5 million (Q3 2025), $645944.0 (Q2 2025), and $710855.0 (Q1 2025).